[EN] PLASMALOGEN DERIVATIVES AND USES THEREOF<br/>[FR] DÉRIVÉS DE PLASMALOGÈNES ET LEURS UTILISATIONS
申请人:[en]PHOSKA BIOPHARMA PTE. LTD.
公开号:WO2022263927A2
公开(公告)日:2022-12-22
Provided herein are compounds (e.g., compounds of Formulae (I) and (II)), and pharmaceutically acceptable salts, hydrates, solvates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, and prodrugs thereof, and compositions, methods, uses, and kits thereof. The compounds provided herein include plasmalogens and plasmalogen derivatives. The compounds provided herein may cross the blood-brain barrier and/or blood-retinal barrier or be transported by the Mfsd2a protein. Accordingly, such compounds are useful for the treatment and/or prevention of various diseases and conditions (e.g., liver diseases, neurological diseases, ophthalmic diseases, metabolic disorders, mitochondrial diseases, cardiovascular diseases, infectious diseases, pulmonary diseases, skin diseases, genetic diseases, proliferative diseases, inflammatory diseases, autoimmune diseases, hematological diseases, painful conditions, psychiatric disorders, immune disorders, and spleen diseases).